Ormond Beach, FLORIDA2 Active Studies

Parkinsons Disease Clinical Trials in Ormond Beach, FLORIDA

Find 2 actively recruiting parkinsons disease clinical trials in Ormond Beach, FLORIDA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
2,349
Enrolling

Recruiting Parkinsons Disease Studies in Ormond Beach

About Parkinsons Disease Clinical Trials in Ormond Beach

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 2 parkinsons disease clinical trials recruiting participants in Ormond Beach, FLORIDA. These studies are seeking a combined 2,349 participants. Research is being sponsored by AstraZeneca, Verona Pharma plc. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Ormond Beach — FAQ

Are there parkinsons disease clinical trials in Ormond Beach?

Yes, there are 2 parkinsons disease clinical trials currently recruiting in Ormond Beach, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ormond Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ormond Beach research site will contact you about next steps.

Are clinical trials in Ormond Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ormond Beach studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 2 active trials in Ormond Beach are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov